HYDERABAD: Multinational drug company Mylan has said it will invest USD one billion in the next 5-6 years on Capex in India , given the importance of the country's position in world pharma supply-chain, and pitched for the government incentivising research and development activities. Mylan Global President and Executive Director Rajiv Malik said the company had been investing close to about USD 400 million or USD 450 million towards Capex every year and half of it in India. "Half of that has been invested in India as a rule of thumb. During the last six or seven years we have invested more than one billion dollars in India to upkeep and expand the capacities, he said. As long as this network is there (in India), we have no other option but continue to invest at the same pace.

Source: Economic Times September 29, 2019 07:18 UTC